Clinical Trials List
2009-12-01 - 2011-12-31
Phase III
Terminated11
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 蒙恩 Division of Urology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Chih-Chieh Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 洪滿榮 Division of Obstetrics & Gynecology
- Shian-Shiang Wang Division of Urology
- Chuan-Shu Chen Division of Urology
- Jian-Ri Li Division of Urology
- 陳怡廷 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- 張廷禎 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 黃淑君 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Chieh-Lung Chou Division of Urology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
500 participants
-
Global
1380 participants
